#DrugScreening
Last day at #AACR and Sakthi Srinivasan, PhD and Helena Laven will present exciting data from Immuneed 🌟🥳 www.immuneed.com

lnkd.in/dxAZe5mk

#oligotherapeutics #drugscreening #safety #modeofaction #therapeutics #drugdevelopment #nonclinical #preclinical #clinical #exvivo #human #3R

👉

🧬💊🩸💉
April 30, 2025 at 11:04 AM
Intelligent Bio Solutions ( #Nasdaq: #INBS ) adds Spanish & Arabic to its #drugscreening tech — opening doors to global markets.

VPs Peter Passaris & Callistus Sequeira share insights on expansion, ops, & regulatory momentum in this interview.

🎙️ Tune in: youtu.be/WwFFKVbDC5U?...
How Intelligent Bio Solutions ($INBS) is Building a Global Footprint
YouTube video by Stocks To Watch
youtu.be
July 9, 2025 at 5:01 PM
Interested in a high-throughput, cost effective #RNAseq method for #drugscreening? Join our webinar this Thursday!
March 31, 2025 at 12:15 PM
Introducing #HaloScreening: a ready-to-use 96-well #cellculture plate embedded with microfibrous 3D PLLA #scaffolds, produced with patented HaloSpin technology!

Specifically designed for #HTS in industrial or research settings.
ilexlife.com/products/gel...

#3Dcellculture #drugscreening #toxicology
HaloScreening - PLLA Scaffolds in 96-well Cell Culture Plate for HTS
Gelatex Technologies introduces HaloScreening: a ready-to-use, 96-well HTS cell culture plate embedded with microfibrous 3D PLLA scaffolds, produced using HaloSpin patented technology!
ilexlife.com
February 28, 2025 at 9:31 PM
In summary, we introduce a scalable anti-TM #drugscreening platform and reveal PKC activation as a TM master-regulator.
TM targeting disconnects tumor networks and sensitizes #GBM to #therapy.

#Translational #CancerNeuroscience
October 9, 2025 at 8:52 PM
🎉 #PhD Unlocked! 🚀🎓 We’re excited to celebrate the success of Fulya Ersoy, who defended her #DoctoralThesis! Fulya pioneered non-invasive 3D neuro-microphysiological systems #MPS to advance our understanding of #CentralNervousSystem and enhance #DrugScreening applications!
Congratulations Dr. Ersoy!
November 12, 2024 at 10:09 AM
New paper out from Patrick Wagner Group! We tested a prototype HTM (heat transfer method) device to assess antimicrobial efficacy.

#Biophysics #HTM #Biosensors #Antimicrobials #COMSOL #DrugScreening

More information here: www.mdpi.com/1424-8220/25...
May 7, 2025 at 11:55 AM
🚀 Meet µOrganoLab #PostDoc Nicole Anderle at the “Immune Niches in Cancer & Inflammation” #INCI25 conference in Bruges today! 🇧🇪
📊 Stop by at her poster during Poster Session 1 and explore our microfluidic #TumorOnChip systems for personalized #DrugScreening and tumor-immune interaction modeling! 🙌
May 7, 2025 at 8:09 AM
November 4, 2025 at 7:47 PM
#PainRelief using animal venoms: Sharma et al. apply their #insilico #screening method to identify and confirm a novel #ionchannel inhibitor with therapeutic potential. #drugscreening #rationalengineering #inhibitor #molecularmedicine

➡️ doi.org/10.1002/1873-3468.70036
April 7, 2025 at 11:00 AM
It's STANDARD in every industry that #DrugScreening is required BEFORE ANY consideration of candidacy for #employment
April 2, 2025 at 11:33 PM
Epileptiform-like events were electrically induced using a biphasic ±1000 mV pulse waveform with inter-burst intervals (IBIs) up to 2 s.
doi.org/10.1111/epi....

#epilepsy #epilepsia #ILAE #antiseizuremedications #drugscreening #electricalstimulation #multielectrodearray
August 17, 2025 at 7:46 PM
CXCR4, an emerging key therapeutic target. Conigen is developing an innovative #CXCR4 platform for conducting in vivo animal #immunization and in vitro #bioassays. This platform supports research in areas such as #receptorligandinteractions, #drugscreening, and #mechanisticstudies. bit.ly/3ONMzlL
CXCR4: A Critical Player in Cancer, Immunity, and Therapeutic Innovation - Conigen Bioscience
The CXCR4-CMP is stable and bioactive. It can be specifically and potently bound by CXCR4-specific antibody, and more importantly, it can bind to its ligand CXCL12 and HIV-1 envelope glycoprotein.
bit.ly
December 11, 2024 at 7:14 PM
Happy to share our latest work by Verheul, Fabro etal, describing our optimized protocol for establishing GBM cell cultures. Another step forward to personalized drugscreening for GBM patients! Thank you to everyone who contributed.🙏𝗡𝗮𝘁𝘂𝗿𝗲 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆(2025)
🔗 www.nature.com/articles/s41...
June 10, 2025 at 10:09 PM
🧪🔍 Keeping workplaces & communities safe! The #DrugScreening market in North America is growing with advanced testing solutions 🚀🌍
#Healthcare #Diagnostics #PublicHealth

www.marketresearchfuture.com/reports/nort...
North America Drug Screening Market Growth Report 2032
North America Drug Screening industry is projected to grow from USD 4.93 Billion in 2024 to USD 13.69 Billion by 2032, at a CAGR of 13.91% during the forecast period (2024 - 2032).
www.marketresearchfuture.com
August 21, 2025 at 10:43 AM